6.
Yao J, Zhang Y, Shen J, Lei Z, Xiong J, Feng B
. AI diagnosis of Bethesda category IV thyroid nodules. iScience. 2023; 26(11):108114.
PMC: 10589877.
DOI: 10.1016/j.isci.2023.108114.
View
7.
Zhou J, Yin L, Wei X, Zhang S, Song Y, Luo B
. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 2020; 70(2):256-279.
DOI: 10.1007/s12020-020-02441-y.
View
8.
Durante C, Grani G, Lamartina L, Filetti S, Mandel S, Cooper D
. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018; 319(9):914-924.
DOI: 10.1001/jama.2018.0898.
View
9.
Jiang M, Li C, Tang S, Lv W, Yi A, Wang B
. Nomogram Based on Shear-Wave Elastography Radiomics Can Improve Preoperative Cervical Lymph Node Staging for Papillary Thyroid Carcinoma. Thyroid. 2020; 30(6):885-897.
DOI: 10.1089/thy.2019.0780.
View
10.
Liu J, Luo T, Zhang H, Liu H, Gu Y, Chen X
. Markedly hypoechoic: a new definition improves the diagnostic performance of thyroid ultrasound. Eur Radiol. 2023; 33(11):7857-7865.
DOI: 10.1007/s00330-023-09828-1.
View
11.
Muri R, Trippel M, Borner U, Weidner S, Trepp R
. The Impact of Rapid On-Site Evaluation on the Quality and Diagnostic Value of Thyroid Nodule Fine-Needle Aspirations. Thyroid. 2022; 32(6):667-674.
DOI: 10.1089/thy.2021.0551.
View
12.
Wildman-Tobriner B, Buda M, Hoang J, Middleton W, Thayer D, Short R
. Using Artificial Intelligence to Revise ACR TI-RADS Risk Stratification of Thyroid Nodules: Diagnostic Accuracy and Utility. Radiology. 2019; 292(1):112-119.
DOI: 10.1148/radiol.2019182128.
View
13.
Hess J, Van Tassel D, Runyan C, Morrison Z, Walsh A, Schafernak K
. Performance of ACR TI-RADS and the Bethesda System in Predicting Risk of Malignancy in Thyroid Nodules at a Large Children's Hospital and a Comprehensive Review of the Pediatric Literature. Cancers (Basel). 2023; 15(15).
PMC: 10417028.
DOI: 10.3390/cancers15153975.
View
14.
Qi Q, Zhou A, Guo S, Huang X, Chen S, Li Y
. Explore the Diagnostic Efficiency of Chinese Thyroid Imaging Reporting and Data Systems by Comparing With the Other Four Systems (ACR TI-RADS, Kwak-TIRADS, KSThR-TIRADS, and EU-TIRADS): A Single-Center Study. Front Endocrinol (Lausanne). 2021; 12:763897.
PMC: 8578891.
DOI: 10.3389/fendo.2021.763897.
View
15.
Houdek D, Cooke-Hubley S, Puttagunta L, Morrish D
. Factors affecting thyroid nodule fine needle aspiration non-diagnostic rates: a retrospective association study of 1975 thyroid biopsies. Thyroid Res. 2021; 14(1):2.
PMC: 7874649.
DOI: 10.1186/s13044-021-00093-2.
View
16.
Garcia Pascual L, Surralles M, Morlius X, Minguez C, Viscasillas G, Lao X
. Ultrasound-guided fine needle aspiration of thyroid nodules with on-site cytological examination: Diagnostic efficacy, prevalence, and factors predicting for Bethesda category I results. Endocrinol Diabetes Nutr (Engl Ed). 2019; 66(8):495-501.
DOI: 10.1016/j.endinu.2018.12.006.
View
17.
Juhlin C, Baloch Z
. The 3 Edition of Bethesda System for Reporting Thyroid Cytopathology: Highlights and Comments. Endocr Pathol. 2023; 35(1):77-79.
DOI: 10.1007/s12022-023-09795-9.
View
18.
Ali S, Baloch Z, Cochand-Priollet B, Schmitt F, Vielh P, VanderLaan P
. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2023; 33(9):1039-1044.
DOI: 10.1089/thy.2023.0141.
View
19.
Polkowski M
. With or without ROSE: does fine-needle biopsy settle the debate on rapid on-site evaluation?. Endoscopy. 2021; 54(1):13-15.
DOI: 10.1055/a-1513-0564.
View
20.
Chen D, Lang B, McLeod D, Newbold K, Haymart M
. Thyroid cancer. Lancet. 2023; 401(10387):1531-1544.
DOI: 10.1016/S0140-6736(23)00020-X.
View